Company intelligence / Profile preview

Viscofan

Pamplona / Aranguren, Navarra, Spainviscofan.com ↗

Ownership: Private
Employees: ~5323
Development stage: Commercial

Overview

Viscofan BioEngineering supplies ultrapure bovine collagen type-I scaffolds and bulk materials used globally in regenerative medicine R&D, medical device prototyping, bioprinting applications, and advanced cell/tissue culture. Their products are recognized for high purity and biocompatibility. The Collagen Cell Carrier® has been used in advanced intestine-on-chip systems developed by academic partners. No proprietary drug pipeline or clinical trial results.

Therapeutic areas: Other
Modalities: Protein (collagen-based biomaterials)Biomaterial scaffoldDevice (collagen matrices for medical technologies and regenerative medicine)
Industry: Chemicals & Materials

Partnerships

Academic collaborations with ETH Zurich on organ-on-chip models using their collagen scaffolds

Beyond the preview

Go deeper on Viscofan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viscofan.

Explore the full profile